bioAffinity (BIAF) Tops Q2 EPS by 146c
Tweet
Share
E-mailGet Alerts BIAF Hot Sheet
Join SI Premium – FREE
bioAffinity (NASDAQ: BIAF) reported Q2 EPS of ($0.64), $1.46 better than the analyst estimate of ($2.10). Revenue for the quarter came in at $1.5 million versus the consensus estimate of $1.7 million.
For earnings history and earnings-related data on bioAffinity (BIAF) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- Goldgroup Mining launches $75M private placement with $60M committed
- BMO Capital Starts Carter's (CRI) at Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
